Research
-
Call in the T-Cell Cavalry to Fight COVID in the Immunocompromised (OPINION-MedPage Today)
The normal vaccine response that elicits antibodies and immune cells to fight infection are absent in these immunocompromised individuals, who…
Read More » -
COVID-19 survivors may possess wide-ranging resistance to the disease (Emory)
Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is…
Read More » -
Thai study looks at CoronaVac vaccine vs. natural immunity to SARS-COV-2 variants
The authors of this study reported that the WT strain of SARS-CoV-2 was best neutralized by Natural Infection 2020 when…
Read More » -
Rethinking Covid-19 Vaccine Mandates (Physician Outlook)
A word of caution to all employers, schools, and universities considering mandates: just because one can legally implement such mandates,…
Read More » -
Study Finds COVID-19 Reinfection Rate Less Than 1% for Those with Severe Illness (U. Missouri School of Medicine)
A review of more than 9,000 U.S. patients with severe COVID-19 infection showed less than 1% contracted the illness again,…
Read More » -
Lymph Node Findings on PET: Cancer or COVID Vaccine?
The decision to proceed with PET imaging after recent COVID-19 vaccination should take into account the evolving knowledge of the…
Read More » -
Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants
A number of case studies like this one now demonstrate that some patients with severely weakened immune systems can take…
Read More » -
T cells recognize recent SARS-CoV-2 variants (NIH News Release)
When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective…
Read More » -
Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study
Conclusions: Prior infection in patients with COVID-19 was highly protective against reinfection and symptomatic disease. This protection increased over time,…
Read More » -
Outcome Reporting Bias in COVID-19 mRNA Vaccine Clinical Trials
CONCLUSION: A critical appraisal of phase III clinical trial data for the Pfizer/BioNTech vaccine BNT162b2 and Moderna vaccine mRNA-1273 shows…
Read More »
